Someone also posted Elto was worthless but it appe
Post# of 30027
Did they get better with age like MANF, Elto and ESS or worthless as you say. One thing I know for sure is people still cant get easily tested for any of this so the market is still wide open.
Be interesting if AMBS createa a sub for dx, include MANF biomarker for 4-5 indication, spin it off and uplist.